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ABSTRACT
The microbiological transformation of ent-beyer-15-en-18-ol 1 and ent-beyer-15-en-19-ol 2, using Mucor plumbeus, resulted in hydroxylated products. After 
nine days of incubation, 15β,16β-epoxide-ent-beyeran-7b,18-diol 3, ent-beyer-15-en-7b,19-diol 4 and 15β,16β-epoxide-ent-beyeran-7b,19-diol 5 were isolated. 
The metabolites were identified by spectroscopic methods. 
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INTRODUCTION
Biotransformation is today considered to be an economically competitive 
technology by synthetic organic chemists in search of new production routes 
for fine chemical, pharmaceutical and agrochemical compounds1. From 
the different transformations catalyzed by enzymatic systems, the selective 
hydroxylation of non-activated carbon atoms is particularly interesting, 
because this transformation is difficult to achieve by classical methods2,3. 
The introduction of hydroxyl groups in diterpenoids may enhance existing 
properties or lead to new biological activities. Microbial transformations have 
been used to introduce hydroxyl groups at positions remote from the functional 
group on diterpenoid molecules, such as stemodanes4 , kaurenes5, pimaranes6, 
among others. We had carried out the biotransformation of ent–beyerene 
derivatives with Giberella fujikuroi (analogue biosynthesis) concluding that 
the presence of a 18 hydroxyl in the molecule is inhibitory for the formation 
of the gibberellins7,8. Although several microbial hydroxylations on beyerane 
derivatives9-11 have been described, to the best of our knowledge, there are no 
reports about biotransformation of ent-beyer-15-ene with Mucor plumbeus. In 
this work we describe the isolation and structural elucidation of the xenobiotic 
biotransformation of ent-beyer-15-en-18-ol, 1 and ent-beyer-15-en-19-ol, 2 
with M. plumbeus
EXPERIMENTAL
General procedures.- 1H NMR spectra were recorded in CDCl3 solution at 
400.13 MHz , and the 13C NMR at 125.03 MHz in a Bruker multidimensional 
spectrometer. Purification by HPLC was achieved using a silica gel column 
(Ultrasphere Si 5 lm, 10 - 250 mm). Dry column chromatography was made on 
silica gel Merck 0.040–0.063 mm.
Microorganism.-The fungal strain was M. plumbeus CMI 116688 was a 
gift from Prof. M. Fraga Universidad de La Laguna, Tenerife, Spain.
Incubation procedure.- The fungus M. plumbeus,  was grown on shake 
culture at 25°C for two days in 80 conical flasks (250 mL), each containing 
50 mL of sterile medium comprising (per dm3) glucose (80 g), NH4NO3 (0.48 
g), KH2PO4 (5 g), MgSO4(1 g), and trace elements solution (2 mL). The trace 
elements solution contained (per 100 mL) Co(NO3)2 (0.01 g), CuSO4 (0.015 
g), ZnSO4 (0.16 g), MnSO4 (0.01 g), (NH4)6Mo7O24 (0.01 g). The substrate 
dissolved in EtOH (11–16 mL) and Tween 80 (three drops) was evenly 
distributed between the flasks and the incubation allowed to continue for a 
further 9 days. The broth was filtered and the culture filtrate extracted with 
EtOAc. The mycelium was treated with liquid nitrogen, crushed in a mortar 
and extracted with EtOAc. Both extracts were combined and separated into 
‘acidic’ and ‘neutral’ fractions with aqueous NaHCO3.
 Incubation of ent-beyer-15-en-18-ol, 1: The substrate 1 (300 mg) in EtOH 
(20 mL) was distributed between 80 conical flasks. Its biotransformation gave 
in the neutral fraction, starting material (130 mg) and 15β,16β- epoxide-ent-
beyeran-7b,18-diol 3 (20 mg) and 15β,16β- epoxide-ent-beyeran-7b,19-diol, 4 
(45 mg). Transformed products were not obtained in the acid fraction.
15β,16 β-epoxide-ent-beyeran-7b,18-diol, 3: 1H NMR (400 MHz, CDCl3): 
4.02 (1H, t, J= 3.0 Hz, H-7), 3.6 (1H, d, J= 11.0 Hz, H-18), 3.3 (1H, d, J= 3.0 
Hz, H-15), 3.1 (1H,d, J= 3.0 Hz, H-16), 2.9 (1H, d, J= 11.0 Hz, H-18’ ), 1.06 (3 
H, s, Me -17) 0.95 (3H,s, Me -20), 0.75 (3 H, s, Me-19).13C NMR: see Table 1
Incubation of ent-beyer-15-en-19-ol, 2: The substrate 2 (300 mg) in EtOH 
(20 mL) was distributed between 80 conical flasks. Its biotransformation gave 
in the neutral fraction, starting material (130 mg), ent-beyer-15-en-7b,19-diol 4 
(40 mg) and 15β,16 β- epoxide-ent-beyeran-7b,19- diol (5) (50 mg). 13C NMR: 
see Table 1
Table 1. 13C NMR data of Compounds 1 – 5 (CDCl3, d in ppm)
Carbon Nº 1* 2* 3 4 5
1 38.8 39.2 39.3 39.3 39.3
2 18.0 18.3 18.2 18.5 18.1
3 35.4 35.7 35.3 35.9 35.5
4 37.6 38.5 37.6 38.2 37.5
5 49.1 56.8 39.4 47.2 47.4
6 19.9 20.1 27.3 27.9 27.7
7 37.0 37.3 70.7 73.5 70.1
8 48.6 49.0 49.6 54.6 49.2
9 52.8 53.0 51.3 47.8 50.7
10 37.1 37.3 37.2 37.5 37.9
11 20.3 20.3 19.5 20.2 19.1
12 33.3 33.2 35.3 33.1 35.0
13 43.6 43.6 39.5 44.3 39.1
14 61.2 61.2 42.5 56.8 42.3
15 135.0 135.0 55.8 133.5 55.4
16 136.0 136.5 60.0 136.5 59.7
17 24.9 24.9 21.7 25.1 21.5
18 72.3 27 71.2 27.0 26.7
19 17.7  65.5 18.0 66.1 65.7
20 15.6 15.6 15.9 15.5 15.8
*Values in these columns were taken from the literature11
ent-beyer-15-en-7b,19-diol, 4: 1H NMR (400 MHz, CDCl3): 5.53 (1H, d 
J= 5.7 Hz, H-15), 5.49 (1H,d J= 5.7 Hz, H-16), 3.76 (1H, d,J= 10.9 Hz, H-19), 
3.68 (1H, t J= 2.7 Hz, H-7), 3.45 (1H, d, J= 10.9 Hz, H-19¨), 1.04 (3 H, s, Me-
18), 0.98 (3H,s, Me -H), 0.73 (3 H, s, Me- 20). 13C NMR: see Table 1
15β,16β-epoxide-ent-beyeran-7b,19-diol, 5: 1H NMR (400 MHz, CDCl3): 
3.99 (1H, bt , J= 2.6 Hz, H-7), 3.77 (1H, d, J= 11Hz,  H-19), 3.48 (1H, d, J= 11 
Hz, H-19’ ), 3.30 (1H, d, J= 2.9 Hz, H-15), 3.07 (1H,d, J= 2.9 Hz, H-16), 1.06 
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(3H, s, Me-17), 0.99 (3H, s, Me-18), 0.91 (3H, s, Me-20), 1.23 (1H, dd, J= 2.8 
and 10.8 Hz, H-14) 0.79 (1H, d, J= 10.8 Hz H-14´).13C NMR: see Table 1
Figure 1: Natural and Biotransformed terpenes.
RESULTS AND DISCUSSION
Baccharis tola (Compositae), popularly known as ‘‘ñaka or lejía” is a 
perennial herb that grows wild in Antofagasta, Chile. Previous phytochemical 
studies of these plant established the presence of the triterpene oleanolic 
acid, as well as two ent-beyerene –type diterpenoids, ent-beyer-15-en-18-ol, 
1 and ent-beyer-15-en-19-ol, 2. These diterpenoids are rare and little-studied 
biologically thus far11.
Each substrates were added to 36 hours-old shake cultures of M. plumbeus 
and the metabolites were extracted after a further 9  days, combined broth and 
mycelium extract were chromatographed eluting with mixtures of petroleum 
ether-EtOAc of increasing polarity. The fermentation of ent-beyer-15-en-18-ol, 
1 afforded compound 3, and the fermentation of ent-beyer-15-en-19-ol, 2 gave 
compounds 4 and 5. The 1H NMR spectrum of 3 was very similar to that of 1 
with the disappearance of the olefinic protons in 1 at D 5.60 and 5.43 (d, J=6Hz, 
1H each) and the appearance of two doublets at D 3.3 and 3.1 (1H each, d, J=3.0 
Hz) corresponding to the protons of an oxirane ring and a broad triplet at D 4.02 
corresponding to a methine proton bearing an hydroxyl group. The position 
of the newly introduce hydroxyl (C-7) was established by unambiguous 
assignments of all carbons and protons through combined use of HMQC, 
HMBC and COSY 45 spectra. The HMBC spectrum of 3 showed correlation 
of H-7 (d 4.02 brt) with C-5 (d 39.4) and C-9 (d 51.3). The D stereochemistry 
of the hydroxyl group al C-7 was established by the pattern of H-7eq  D 4.02 
(t, J=3 Hz). Furthermore, Me-17 was shifted from D 0.77 in 1 to D 1.06 in 3 
indicating that the oxirane ring must be between C-15 and C-16 and confirmed 
by the HMBC spectrum, which showed correlations between Me-17 (D 1.06) 
and C-16 (D 60. 0), C-12 (d 35.3) and C-14 (d 42.5). It is of interest to note that 
in the 13C NMR spectrum of this compound, the pronounced shielding effect 
exerted by the 15,16 epoxide on C–14. (Dd1-3-18.7). The (CH2)14 signal appears 
as a doublet doublet instead of a triplet in the spectrum of 1 indicating the β 
orientation of the epoxide ring12. So, compound 3 must be 15β,16β-epoxide-
ent-beyeran-7D,18-diol. The fermentation of ent-beyer-15-en-19-ol, 2, gave 
compounds 4 and 5 see Figure 1.
The 1H NMR spectrum of 4 was very similar to that of 1. The 1H NMR 
spectrum of 4 shows methyl signals at D 1.04, 0.98 and 0.73, a collapsed AB 
system at D 5.50 assigned to a Z olefin with no hydrogens at the vicinal carbon 
atoms, a QAB systems with J = 10.9 Hz and signals centered at D 3.76 and 3.45 
attributable to the -CH2OH group situated at C-19. A signal at D 3.68 (bt, J = 2.7 
Hz) attributable proton geminal to an hydroxyl group. The chemical shift and 
form of the signal of this proton described may be due to an equatorial proton 
geminal to the hydroxyl group. The position of these newly introduce hydroxyl 
(C-7) was confirmed by 13C NMR spectrum (Table 1). The signal for C–5 was 
shifted upfield by Dd1-4 9.6 ppm, C-9, C-14 and C-15 were shifted upfield by 
Dd1-3 5.2, 4.4 and 1.5 respectively and C-6 and C-8 were shifted downfield 
by Dd1-4 7.8 and 5.6 ppm. Therefore, compound 4 must be ent-beyer–15-en-7 
b,19-diol. 
The 1H NMR spectrum of compound 5 is very similar to that of 3.The only 
differences are the signals corresponding to the hydroxymethylene which are 
shifted from DH 3.6 and 2.9 in 3 to D 3.77 and 3.48 (1H each, d, J=11.0 Hz) and 
DC from 71.2 to 66.1 ppm in 5 which is indicative of the hydroxyl in C-19. So 
compound 5 must be 15β, 16 β- epoxide-ent-beyeran-7 D,19-diol.
CONCLUSIONS
The presence of an hydroxyl group at C-18 or C-19 does not affect the 
hydroxylation pattern with M. plumbeus. A different situation was observed 
in the biotransformation of these products with G. fujikuroi, where only 
compound 2 produced gibberellines and compound 1 produced hydroxylation 
at C-7 and C-197.
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